LENZ Therapeutics, Inc.
LENZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | 100% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -69.8% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -72.1% | – |
| EPS Diluted | -2.34 | -15.3 | -12.891 | -8.538 |
| % Growth | 84.7% | -18.7% | -51% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |